HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Parlux Fragrances

This article was originally published in The Rose Sheet

Executive Summary

Parlux Fragrances: Retains Montgomery Securities to "explore the alternatives for increasing shareholder value," including a possible sale or merger of the company, Parlux said Nov. 26. The firm calls its sales and income record "impressive," but maintained that "Wall Street valuation of Parlux is well below standards for...companies with comparable luxury...properties" because of earnings-per-share declines. For the first six months of FY 1997 (ended Sept. 30), Parlux' eps was 25 [cents] versus 26 [cents] in the year-ago period. The Montgomery hire is a result of Parlux' board authorizing the firm to "pursue all reasonable actions to enhance shareholder value" in September ("The Rose Sheet" Sept. 16, In Brief). In May, Parlux retained Salomon Brothers to explore its "strategic advantages"; that deal ended when Parlux signed a letter of intent with Haas Wheat & Partners extending terms of its $40 mil. debenture arrangement to 20 years ("The Rose Sheet" June 3, In Brief). Those discussions were terminated June 12...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS003509

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel